Clinical Outcomes and Healthcare Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HF

By afschroeder • November 11, 2025

Shoji S, Ikeaba U, Fonarow GC, Selvaraj S, Lewsey SC, Pandey A, Khouri MG, Alhanti B, McDermott JJ, Wright J, Vaduganathan M, Greene SJ. Clinical Outcomes and Healthcare Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HF. J Card Fail. 2025 Nov 8:S1071-9164(25)00508-1. doi: 10.1016/j.cardfail.2025.10.007. Epub ahead of print. PMID: 41213322.

Tags: Cardiology/Epi, healthcare costs, heart failure, hospital readmission, Medicare, Publications, transthyretin amyloid cardiomyopathy

Association of Polygenic Risk Scores With Aortic Valve Calcium: The Multi-Ethnic Study of Atherosclerosis

Whelton SP, Yao J, Clish C, Wood AC, Taylor KD, Blaha MJ, Budoff M, Marrero N, Thanassoulis G, Post WS, Guo X, Rotter JI. Association[...]

Interventional procedures in congenital heart disease for atrio-ventricular valves: future possibility or fools dream

Linnane N, Kenny D. Interventional procedures in congenital heart disease for atrio-ventricular valves: future possibility or fools dream. Curr Opin Cardiol. 2026 May 5. doi:[...]

Cardiovascular-specific PTH1R activation enhances exercise-induced cardiac remodeling in a mouse model of calcific atherosclerosis

Hon A, Lu M, Shao XM, Demer LL, Tintut Y. Cardiovascular-specific PTH1R activation enhances exercise-induced cardiac remodeling in a mouse model of calcific atherosclerosis. Biochem[...]